nodes	percent_of_prediction	percent_of_DWPC	metapath
Iodixanol—Serum creatinine increased—Doxorubicin—liver cancer	0.00812	0.00812	CcSEcCtD
Iodixanol—Acute coronary syndrome—Sorafenib—liver cancer	0.00806	0.00806	CcSEcCtD
Iodixanol—Myocardial infarction—Sorafenib—liver cancer	0.00801	0.00801	CcSEcCtD
Iodixanol—Hypokinesia—Epirubicin—liver cancer	0.008	0.008	CcSEcCtD
Iodixanol—Parosmia—Doxorubicin—liver cancer	0.0077	0.0077	CcSEcCtD
Iodixanol—Thrombosis—Epirubicin—liver cancer	0.00763	0.00763	CcSEcCtD
Iodixanol—Hypokinesia—Doxorubicin—liver cancer	0.0074	0.0074	CcSEcCtD
Iodixanol—Ventricular arrhythmia—Epirubicin—liver cancer	0.00729	0.00729	CcSEcCtD
Iodixanol—Urinary tract disorder—Sorafenib—liver cancer	0.00724	0.00724	CcSEcCtD
Iodixanol—Urethral disorder—Sorafenib—liver cancer	0.00719	0.00719	CcSEcCtD
Iodixanol—Scotoma—Epirubicin—liver cancer	0.00711	0.00711	CcSEcCtD
Iodixanol—Thrombosis—Doxorubicin—liver cancer	0.00706	0.00706	CcSEcCtD
Iodixanol—Rash erythematous—Epirubicin—liver cancer	0.00705	0.00705	CcSEcCtD
Iodixanol—Feeling hot—Epirubicin—liver cancer	0.00688	0.00688	CcSEcCtD
Iodixanol—Tinnitus—Sorafenib—liver cancer	0.00684	0.00684	CcSEcCtD
Iodixanol—Cardiac disorder—Sorafenib—liver cancer	0.00681	0.00681	CcSEcCtD
Iodixanol—Flushing—Sorafenib—liver cancer	0.00681	0.00681	CcSEcCtD
Iodixanol—Ventricular arrhythmia—Doxorubicin—liver cancer	0.00675	0.00675	CcSEcCtD
Iodixanol—Angiopathy—Sorafenib—liver cancer	0.00666	0.00666	CcSEcCtD
Iodixanol—Immune system disorder—Sorafenib—liver cancer	0.00663	0.00663	CcSEcCtD
Iodixanol—Rigors—Epirubicin—liver cancer	0.00661	0.00661	CcSEcCtD
Iodixanol—Injection site pain—Epirubicin—liver cancer	0.00661	0.00661	CcSEcCtD
Iodixanol—Scotoma—Doxorubicin—liver cancer	0.00658	0.00658	CcSEcCtD
Iodixanol—Rash erythematous—Doxorubicin—liver cancer	0.00652	0.00652	CcSEcCtD
Iodixanol—Mental disorder—Sorafenib—liver cancer	0.00643	0.00643	CcSEcCtD
Iodixanol—Erythema—Sorafenib—liver cancer	0.00639	0.00639	CcSEcCtD
Iodixanol—Feeling hot—Doxorubicin—liver cancer	0.00636	0.00636	CcSEcCtD
Iodixanol—Dysgeusia—Sorafenib—liver cancer	0.00625	0.00625	CcSEcCtD
Iodixanol—Muscle spasms—Sorafenib—liver cancer	0.00614	0.00614	CcSEcCtD
Iodixanol—Injection site pain—Doxorubicin—liver cancer	0.00612	0.00612	CcSEcCtD
Iodixanol—Rigors—Doxorubicin—liver cancer	0.00612	0.00612	CcSEcCtD
Iodixanol—Bone disorder—Epirubicin—liver cancer	0.00598	0.00598	CcSEcCtD
Iodixanol—Angioedema—Sorafenib—liver cancer	0.00584	0.00584	CcSEcCtD
Iodixanol—Syncope—Sorafenib—liver cancer	0.00573	0.00573	CcSEcCtD
Iodixanol—Loss of consciousness—Sorafenib—liver cancer	0.00561	0.00561	CcSEcCtD
Iodixanol—Cough—Sorafenib—liver cancer	0.00557	0.00557	CcSEcCtD
Iodixanol—Bone disorder—Doxorubicin—liver cancer	0.00553	0.00553	CcSEcCtD
Iodixanol—Hypertension—Sorafenib—liver cancer	0.00551	0.00551	CcSEcCtD
Iodixanol—Arthralgia—Sorafenib—liver cancer	0.00544	0.00544	CcSEcCtD
Iodixanol—Injection site reaction—Epirubicin—liver cancer	0.00537	0.00537	CcSEcCtD
Iodixanol—Dry mouth—Sorafenib—liver cancer	0.00532	0.00532	CcSEcCtD
Iodixanol—Salivary hypersecretion—Epirubicin—liver cancer	0.00524	0.00524	CcSEcCtD
Iodixanol—Anaphylactic shock—Sorafenib—liver cancer	0.00521	0.00521	CcSEcCtD
Iodixanol—Shock—Sorafenib—liver cancer	0.00513	0.00513	CcSEcCtD
Iodixanol—Nervous system disorder—Sorafenib—liver cancer	0.00511	0.00511	CcSEcCtD
Iodixanol—Blood urea increased—Epirubicin—liver cancer	0.0051	0.0051	CcSEcCtD
Iodixanol—Injection site reaction—Doxorubicin—liver cancer	0.00497	0.00497	CcSEcCtD
Iodixanol—Cramps of lower extremities—Epirubicin—liver cancer	0.00496	0.00496	CcSEcCtD
Iodixanol—Coma—Epirubicin—liver cancer	0.00493	0.00493	CcSEcCtD
Iodixanol—Oesophagitis—Epirubicin—liver cancer	0.00493	0.00493	CcSEcCtD
Iodixanol—Salivary hypersecretion—Doxorubicin—liver cancer	0.00485	0.00485	CcSEcCtD
Iodixanol—Pulmonary oedema—Epirubicin—liver cancer	0.00481	0.00481	CcSEcCtD
Iodixanol—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00475	0.00475	CcSEcCtD
Iodixanol—Blood urea increased—Doxorubicin—liver cancer	0.00472	0.00472	CcSEcCtD
Iodixanol—Abnormal vision—Epirubicin—liver cancer	0.00471	0.00471	CcSEcCtD
Iodixanol—Dyspnoea—Sorafenib—liver cancer	0.00465	0.00465	CcSEcCtD
Iodixanol—Cramps of lower extremities—Doxorubicin—liver cancer	0.00459	0.00459	CcSEcCtD
Iodixanol—Dyspepsia—Sorafenib—liver cancer	0.00459	0.00459	CcSEcCtD
Iodixanol—Coma—Doxorubicin—liver cancer	0.00456	0.00456	CcSEcCtD
Iodixanol—Oesophagitis—Doxorubicin—liver cancer	0.00456	0.00456	CcSEcCtD
Iodixanol—Thrombophlebitis—Epirubicin—liver cancer	0.00453	0.00453	CcSEcCtD
Iodixanol—Gastrointestinal disorder—Sorafenib—liver cancer	0.0045	0.0045	CcSEcCtD
Iodixanol—Fatigue—Sorafenib—liver cancer	0.00449	0.00449	CcSEcCtD
Iodixanol—Pain—Sorafenib—liver cancer	0.00446	0.00446	CcSEcCtD
Iodixanol—Pulmonary oedema—Doxorubicin—liver cancer	0.00445	0.00445	CcSEcCtD
Iodixanol—Abnormal vision—Doxorubicin—liver cancer	0.00436	0.00436	CcSEcCtD
Iodixanol—Gastrointestinal pain—Sorafenib—liver cancer	0.00426	0.00426	CcSEcCtD
Iodixanol—Renal failure acute—Epirubicin—liver cancer	0.00424	0.00424	CcSEcCtD
Iodixanol—Thrombophlebitis—Doxorubicin—liver cancer	0.00419	0.00419	CcSEcCtD
Iodixanol—Urticaria—Sorafenib—liver cancer	0.00414	0.00414	CcSEcCtD
Iodixanol—Abdominal pain—Sorafenib—liver cancer	0.00412	0.00412	CcSEcCtD
Iodixanol—Body temperature increased—Sorafenib—liver cancer	0.00412	0.00412	CcSEcCtD
Iodixanol—Renal impairment—Epirubicin—liver cancer	0.00412	0.00412	CcSEcCtD
Iodixanol—Anaphylactoid reaction—Epirubicin—liver cancer	0.00405	0.00405	CcSEcCtD
Iodixanol—Cardiac failure—Epirubicin—liver cancer	0.00402	0.00402	CcSEcCtD
Iodixanol—Renal failure acute—Doxorubicin—liver cancer	0.00393	0.00393	CcSEcCtD
Iodixanol—Diplopia—Epirubicin—liver cancer	0.00392	0.00392	CcSEcCtD
Iodixanol—Migraine—Epirubicin—liver cancer	0.00386	0.00386	CcSEcCtD
Iodixanol—Renal impairment—Doxorubicin—liver cancer	0.00381	0.00381	CcSEcCtD
Iodixanol—Face oedema—Epirubicin—liver cancer	0.00378	0.00378	CcSEcCtD
Iodixanol—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00375	0.00375	CcSEcCtD
Iodixanol—Asthenia—Sorafenib—liver cancer	0.00374	0.00374	CcSEcCtD
Iodixanol—Cardiac arrest—Epirubicin—liver cancer	0.00373	0.00373	CcSEcCtD
Iodixanol—Cardiac failure—Doxorubicin—liver cancer	0.00372	0.00372	CcSEcCtD
Iodixanol—Pruritus—Sorafenib—liver cancer	0.00369	0.00369	CcSEcCtD
Iodixanol—Blood creatinine increased—Epirubicin—liver cancer	0.00367	0.00367	CcSEcCtD
Iodixanol—Diplopia—Doxorubicin—liver cancer	0.00363	0.00363	CcSEcCtD
Iodixanol—Dry skin—Epirubicin—liver cancer	0.00359	0.00359	CcSEcCtD
Iodixanol—Migraine—Doxorubicin—liver cancer	0.00357	0.00357	CcSEcCtD
Iodixanol—Diarrhoea—Sorafenib—liver cancer	0.00357	0.00357	CcSEcCtD
Iodixanol—Face oedema—Doxorubicin—liver cancer	0.0035	0.0035	CcSEcCtD
Iodixanol—Cardiac arrest—Doxorubicin—liver cancer	0.00345	0.00345	CcSEcCtD
Iodixanol—Dizziness—Sorafenib—liver cancer	0.00345	0.00345	CcSEcCtD
Iodixanol—Blood creatinine increased—Doxorubicin—liver cancer	0.0034	0.0034	CcSEcCtD
Iodixanol—Asthma—Epirubicin—liver cancer	0.00339	0.00339	CcSEcCtD
Iodixanol—Dry skin—Doxorubicin—liver cancer	0.00332	0.00332	CcSEcCtD
Iodixanol—Vomiting—Sorafenib—liver cancer	0.00331	0.00331	CcSEcCtD
Iodixanol—Angina pectoris—Epirubicin—liver cancer	0.0033	0.0033	CcSEcCtD
Iodixanol—Rash—Sorafenib—liver cancer	0.00329	0.00329	CcSEcCtD
Iodixanol—Dermatitis—Sorafenib—liver cancer	0.00328	0.00328	CcSEcCtD
Iodixanol—Headache—Sorafenib—liver cancer	0.00326	0.00326	CcSEcCtD
Iodixanol—Bronchitis—Epirubicin—liver cancer	0.00326	0.00326	CcSEcCtD
Iodixanol—Upper respiratory tract infection—Epirubicin—liver cancer	0.00315	0.00315	CcSEcCtD
Iodixanol—Asthma—Doxorubicin—liver cancer	0.00313	0.00313	CcSEcCtD
Iodixanol—Nausea—Sorafenib—liver cancer	0.0031	0.0031	CcSEcCtD
Iodixanol—Angina pectoris—Doxorubicin—liver cancer	0.00305	0.00305	CcSEcCtD
Iodixanol—Drowsiness—Epirubicin—liver cancer	0.00302	0.00302	CcSEcCtD
Iodixanol—Bronchitis—Doxorubicin—liver cancer	0.00301	0.00301	CcSEcCtD
Iodixanol—Conjunctivitis—Epirubicin—liver cancer	0.00294	0.00294	CcSEcCtD
Iodixanol—Urinary tract infection—Epirubicin—liver cancer	0.00294	0.00294	CcSEcCtD
Iodixanol—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00291	0.00291	CcSEcCtD
Iodixanol—Haematuria—Epirubicin—liver cancer	0.00288	0.00288	CcSEcCtD
Iodixanol—Sinusitis—Epirubicin—liver cancer	0.00283	0.00283	CcSEcCtD
Iodixanol—Drowsiness—Doxorubicin—liver cancer	0.00279	0.00279	CcSEcCtD
Iodixanol—Bradycardia—Epirubicin—liver cancer	0.00276	0.00276	CcSEcCtD
Iodixanol—Rhinitis—Epirubicin—liver cancer	0.00272	0.00272	CcSEcCtD
Iodixanol—Urinary tract infection—Doxorubicin—liver cancer	0.00272	0.00272	CcSEcCtD
Iodixanol—Conjunctivitis—Doxorubicin—liver cancer	0.00272	0.00272	CcSEcCtD
Iodixanol—Hypoaesthesia—Epirubicin—liver cancer	0.0027	0.0027	CcSEcCtD
Iodixanol—Pharyngitis—Epirubicin—liver cancer	0.00269	0.00269	CcSEcCtD
Iodixanol—Urinary tract disorder—Epirubicin—liver cancer	0.00268	0.00268	CcSEcCtD
Iodixanol—Oedema peripheral—Epirubicin—liver cancer	0.00267	0.00267	CcSEcCtD
Iodixanol—Haematuria—Doxorubicin—liver cancer	0.00266	0.00266	CcSEcCtD
Iodixanol—Urethral disorder—Epirubicin—liver cancer	0.00266	0.00266	CcSEcCtD
Iodixanol—Sinusitis—Doxorubicin—liver cancer	0.00262	0.00262	CcSEcCtD
Iodixanol—Visual impairment—Epirubicin—liver cancer	0.00261	0.00261	CcSEcCtD
Iodixanol—Bradycardia—Doxorubicin—liver cancer	0.00255	0.00255	CcSEcCtD
Iodixanol—Eye disorder—Epirubicin—liver cancer	0.00253	0.00253	CcSEcCtD
Iodixanol—Tinnitus—Epirubicin—liver cancer	0.00253	0.00253	CcSEcCtD
Iodixanol—Flushing—Epirubicin—liver cancer	0.00252	0.00252	CcSEcCtD
Iodixanol—Cardiac disorder—Epirubicin—liver cancer	0.00252	0.00252	CcSEcCtD
Iodixanol—Rhinitis—Doxorubicin—liver cancer	0.00251	0.00251	CcSEcCtD
Iodixanol—Hypoaesthesia—Doxorubicin—liver cancer	0.0025	0.0025	CcSEcCtD
Iodixanol—Pharyngitis—Doxorubicin—liver cancer	0.00249	0.00249	CcSEcCtD
Iodixanol—Urinary tract disorder—Doxorubicin—liver cancer	0.00248	0.00248	CcSEcCtD
Iodixanol—Oedema peripheral—Doxorubicin—liver cancer	0.00247	0.00247	CcSEcCtD
Iodixanol—Angiopathy—Epirubicin—liver cancer	0.00246	0.00246	CcSEcCtD
Iodixanol—Urethral disorder—Doxorubicin—liver cancer	0.00246	0.00246	CcSEcCtD
Iodixanol—Immune system disorder—Epirubicin—liver cancer	0.00245	0.00245	CcSEcCtD
Iodixanol—Chills—Epirubicin—liver cancer	0.00243	0.00243	CcSEcCtD
Iodixanol—Visual impairment—Doxorubicin—liver cancer	0.00242	0.00242	CcSEcCtD
Iodixanol—Mental disorder—Epirubicin—liver cancer	0.00238	0.00238	CcSEcCtD
Iodixanol—Erythema—Epirubicin—liver cancer	0.00236	0.00236	CcSEcCtD
Iodixanol—Eye disorder—Doxorubicin—liver cancer	0.00234	0.00234	CcSEcCtD
Iodixanol—Tinnitus—Doxorubicin—liver cancer	0.00234	0.00234	CcSEcCtD
Iodixanol—Flushing—Doxorubicin—liver cancer	0.00233	0.00233	CcSEcCtD
Iodixanol—Cardiac disorder—Doxorubicin—liver cancer	0.00233	0.00233	CcSEcCtD
Iodixanol—Tension—Epirubicin—liver cancer	0.00232	0.00232	CcSEcCtD
Iodixanol—Dysgeusia—Epirubicin—liver cancer	0.00231	0.00231	CcSEcCtD
Iodixanol—Nervousness—Epirubicin—liver cancer	0.00229	0.00229	CcSEcCtD
Iodixanol—Back pain—Epirubicin—liver cancer	0.00228	0.00228	CcSEcCtD
Iodixanol—Angiopathy—Doxorubicin—liver cancer	0.00228	0.00228	CcSEcCtD
Iodixanol—Muscle spasms—Epirubicin—liver cancer	0.00227	0.00227	CcSEcCtD
Iodixanol—Immune system disorder—Doxorubicin—liver cancer	0.00227	0.00227	CcSEcCtD
Iodixanol—Chills—Doxorubicin—liver cancer	0.00225	0.00225	CcSEcCtD
Iodixanol—Mental disorder—Doxorubicin—liver cancer	0.0022	0.0022	CcSEcCtD
Iodixanol—Ill-defined disorder—Epirubicin—liver cancer	0.00219	0.00219	CcSEcCtD
Iodixanol—Erythema—Doxorubicin—liver cancer	0.00218	0.00218	CcSEcCtD
Iodixanol—Agitation—Epirubicin—liver cancer	0.00217	0.00217	CcSEcCtD
Iodixanol—Tension—Doxorubicin—liver cancer	0.00214	0.00214	CcSEcCtD
Iodixanol—Dysgeusia—Doxorubicin—liver cancer	0.00214	0.00214	CcSEcCtD
Iodixanol—Malaise—Epirubicin—liver cancer	0.00213	0.00213	CcSEcCtD
Iodixanol—Nervousness—Doxorubicin—liver cancer	0.00212	0.00212	CcSEcCtD
Iodixanol—Vertigo—Epirubicin—liver cancer	0.00212	0.00212	CcSEcCtD
Iodixanol—Syncope—Epirubicin—liver cancer	0.00212	0.00212	CcSEcCtD
Iodixanol—Back pain—Doxorubicin—liver cancer	0.00211	0.00211	CcSEcCtD
Iodixanol—Muscle spasms—Doxorubicin—liver cancer	0.0021	0.0021	CcSEcCtD
Iodixanol—Loss of consciousness—Epirubicin—liver cancer	0.00207	0.00207	CcSEcCtD
Iodixanol—Cough—Epirubicin—liver cancer	0.00206	0.00206	CcSEcCtD
Iodixanol—Convulsion—Epirubicin—liver cancer	0.00204	0.00204	CcSEcCtD
Iodixanol—Hypertension—Epirubicin—liver cancer	0.00204	0.00204	CcSEcCtD
Iodixanol—Ill-defined disorder—Doxorubicin—liver cancer	0.00203	0.00203	CcSEcCtD
Iodixanol—Arthralgia—Epirubicin—liver cancer	0.00201	0.00201	CcSEcCtD
Iodixanol—Chest pain—Epirubicin—liver cancer	0.00201	0.00201	CcSEcCtD
Iodixanol—Agitation—Doxorubicin—liver cancer	0.00201	0.00201	CcSEcCtD
Iodixanol—Anxiety—Epirubicin—liver cancer	0.002	0.002	CcSEcCtD
Iodixanol—Discomfort—Epirubicin—liver cancer	0.00199	0.00199	CcSEcCtD
Iodixanol—Malaise—Doxorubicin—liver cancer	0.00197	0.00197	CcSEcCtD
Iodixanol—Dry mouth—Epirubicin—liver cancer	0.00197	0.00197	CcSEcCtD
Iodixanol—Vertigo—Doxorubicin—liver cancer	0.00196	0.00196	CcSEcCtD
Iodixanol—Syncope—Doxorubicin—liver cancer	0.00196	0.00196	CcSEcCtD
Iodixanol—Confusional state—Epirubicin—liver cancer	0.00194	0.00194	CcSEcCtD
Iodixanol—Anaphylactic shock—Epirubicin—liver cancer	0.00193	0.00193	CcSEcCtD
Iodixanol—Oedema—Epirubicin—liver cancer	0.00193	0.00193	CcSEcCtD
Iodixanol—Loss of consciousness—Doxorubicin—liver cancer	0.00192	0.00192	CcSEcCtD
Iodixanol—Cough—Doxorubicin—liver cancer	0.00191	0.00191	CcSEcCtD
Iodixanol—Shock—Epirubicin—liver cancer	0.00189	0.00189	CcSEcCtD
Iodixanol—Convulsion—Doxorubicin—liver cancer	0.00189	0.00189	CcSEcCtD
Iodixanol—Nervous system disorder—Epirubicin—liver cancer	0.00189	0.00189	CcSEcCtD
Iodixanol—Hypertension—Doxorubicin—liver cancer	0.00189	0.00189	CcSEcCtD
Iodixanol—Hyperhidrosis—Epirubicin—liver cancer	0.00186	0.00186	CcSEcCtD
Iodixanol—Arthralgia—Doxorubicin—liver cancer	0.00186	0.00186	CcSEcCtD
Iodixanol—Chest pain—Doxorubicin—liver cancer	0.00186	0.00186	CcSEcCtD
Iodixanol—Anxiety—Doxorubicin—liver cancer	0.00185	0.00185	CcSEcCtD
Iodixanol—Discomfort—Doxorubicin—liver cancer	0.00184	0.00184	CcSEcCtD
Iodixanol—Dry mouth—Doxorubicin—liver cancer	0.00182	0.00182	CcSEcCtD
Iodixanol—Hypotension—Epirubicin—liver cancer	0.0018	0.0018	CcSEcCtD
Iodixanol—Confusional state—Doxorubicin—liver cancer	0.0018	0.0018	CcSEcCtD
Iodixanol—Oedema—Doxorubicin—liver cancer	0.00178	0.00178	CcSEcCtD
Iodixanol—Anaphylactic shock—Doxorubicin—liver cancer	0.00178	0.00178	CcSEcCtD
Iodixanol—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00175	0.00175	CcSEcCtD
Iodixanol—Shock—Doxorubicin—liver cancer	0.00175	0.00175	CcSEcCtD
Iodixanol—Nervous system disorder—Doxorubicin—liver cancer	0.00175	0.00175	CcSEcCtD
Iodixanol—Insomnia—Epirubicin—liver cancer	0.00174	0.00174	CcSEcCtD
Iodixanol—Paraesthesia—Epirubicin—liver cancer	0.00173	0.00173	CcSEcCtD
Iodixanol—Hyperhidrosis—Doxorubicin—liver cancer	0.00172	0.00172	CcSEcCtD
Iodixanol—Dyspnoea—Epirubicin—liver cancer	0.00172	0.00172	CcSEcCtD
Iodixanol—Somnolence—Epirubicin—liver cancer	0.00171	0.00171	CcSEcCtD
Iodixanol—Dyspepsia—Epirubicin—liver cancer	0.0017	0.0017	CcSEcCtD
Iodixanol—Hypotension—Doxorubicin—liver cancer	0.00167	0.00167	CcSEcCtD
Iodixanol—Gastrointestinal disorder—Epirubicin—liver cancer	0.00166	0.00166	CcSEcCtD
Iodixanol—Fatigue—Epirubicin—liver cancer	0.00166	0.00166	CcSEcCtD
Iodixanol—Pain—Epirubicin—liver cancer	0.00165	0.00165	CcSEcCtD
Iodixanol—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00162	0.00162	CcSEcCtD
Iodixanol—Insomnia—Doxorubicin—liver cancer	0.00161	0.00161	CcSEcCtD
Iodixanol—Paraesthesia—Doxorubicin—liver cancer	0.0016	0.0016	CcSEcCtD
Iodixanol—Dyspnoea—Doxorubicin—liver cancer	0.00159	0.00159	CcSEcCtD
Iodixanol—Feeling abnormal—Epirubicin—liver cancer	0.00159	0.00159	CcSEcCtD
Iodixanol—Somnolence—Doxorubicin—liver cancer	0.00158	0.00158	CcSEcCtD
Iodixanol—Gastrointestinal pain—Epirubicin—liver cancer	0.00158	0.00158	CcSEcCtD
Iodixanol—Dyspepsia—Doxorubicin—liver cancer	0.00157	0.00157	CcSEcCtD
Iodixanol—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00154	0.00154	CcSEcCtD
Iodixanol—Fatigue—Doxorubicin—liver cancer	0.00154	0.00154	CcSEcCtD
Iodixanol—Urticaria—Epirubicin—liver cancer	0.00153	0.00153	CcSEcCtD
Iodixanol—Pain—Doxorubicin—liver cancer	0.00152	0.00152	CcSEcCtD
Iodixanol—Abdominal pain—Epirubicin—liver cancer	0.00152	0.00152	CcSEcCtD
Iodixanol—Body temperature increased—Epirubicin—liver cancer	0.00152	0.00152	CcSEcCtD
Iodixanol—Feeling abnormal—Doxorubicin—liver cancer	0.00147	0.00147	CcSEcCtD
Iodixanol—Gastrointestinal pain—Doxorubicin—liver cancer	0.00146	0.00146	CcSEcCtD
Iodixanol—Urticaria—Doxorubicin—liver cancer	0.00142	0.00142	CcSEcCtD
Iodixanol—Body temperature increased—Doxorubicin—liver cancer	0.00141	0.00141	CcSEcCtD
Iodixanol—Abdominal pain—Doxorubicin—liver cancer	0.00141	0.00141	CcSEcCtD
Iodixanol—Asthenia—Epirubicin—liver cancer	0.00138	0.00138	CcSEcCtD
Iodixanol—Pruritus—Epirubicin—liver cancer	0.00136	0.00136	CcSEcCtD
Iodixanol—Diarrhoea—Epirubicin—liver cancer	0.00132	0.00132	CcSEcCtD
Iodixanol—Asthenia—Doxorubicin—liver cancer	0.00128	0.00128	CcSEcCtD
Iodixanol—Dizziness—Epirubicin—liver cancer	0.00127	0.00127	CcSEcCtD
Iodixanol—Pruritus—Doxorubicin—liver cancer	0.00126	0.00126	CcSEcCtD
Iodixanol—Vomiting—Epirubicin—liver cancer	0.00122	0.00122	CcSEcCtD
Iodixanol—Diarrhoea—Doxorubicin—liver cancer	0.00122	0.00122	CcSEcCtD
Iodixanol—Rash—Epirubicin—liver cancer	0.00121	0.00121	CcSEcCtD
Iodixanol—Dermatitis—Epirubicin—liver cancer	0.00121	0.00121	CcSEcCtD
Iodixanol—Headache—Epirubicin—liver cancer	0.00121	0.00121	CcSEcCtD
Iodixanol—Dizziness—Doxorubicin—liver cancer	0.00118	0.00118	CcSEcCtD
Iodixanol—Nausea—Epirubicin—liver cancer	0.00114	0.00114	CcSEcCtD
Iodixanol—Vomiting—Doxorubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Iodixanol—Rash—Doxorubicin—liver cancer	0.00112	0.00112	CcSEcCtD
Iodixanol—Dermatitis—Doxorubicin—liver cancer	0.00112	0.00112	CcSEcCtD
Iodixanol—Headache—Doxorubicin—liver cancer	0.00112	0.00112	CcSEcCtD
Iodixanol—Nausea—Doxorubicin—liver cancer	0.00106	0.00106	CcSEcCtD
